| Literature DB >> 36186517 |
Prayash Katlariwala1, Mitchell P Wilson2, Yeli Pi2, Baljot S Chahal2, Roger Croutze2, Deelan Patel2, Vimal Patel2, Gavin Low2.
Abstract
BACKGROUND: The 2018 ovarian-adnexal reporting and data system (O-RADS) guidelines are aimed at providing a system for consistent reports and risk stratification for ovarian lesions found on ultrasound. It provides key characteristics and findings for lesions, a lexicon of descriptors to communicate findings, and risk characterization and associated follow-up recommendation guidelines. However, the O-RADS guidelines have not been validated in North American institutions or amongst less experienced readers. AIM: To evaluate the diagnostic accuracy and inter-reader reliability of ultrasound O-RADS risk stratification amongst less experienced readers in a North American institution with and without pre-test training.Entities:
Keywords: Accuracy; Malignancy; Ovarian-adnexal reporting and data system; Ovary; Reliability; Ultrasound
Year: 2022 PMID: 36186517 PMCID: PMC9521430 DOI: 10.4329/wjr.v14.i9.319
Source DB: PubMed Journal: World J Radiol ISSN: 1949-8470
Sensitivity, specificity, positive predictive value and negative predictive value per ovarian-adnexal reporting and data system category for each reader on the pre-training assessment
|
|
|
|
|
|
|
|
| |||||
|
| 90 (55.5 to 99.8) | 100 (69.5 to 100) | 100 (59.0 to 100) | 92 (61.5 to 99.8) | 55 (23.4 to 83.3) |
|
| 90% (55.5 to 99.8) | 100% (69.2 to 100) | 71 (29.0 to 96.3) | 92 (61.5 to 99.8) | 82 (48.2 to 97.7) |
|
| 90 (55.5 to 99.8) | 100 (69.2 to 100) | 100 (59.0 to 100) | 75 (42.8 to 94.5) | 55 (23.4 to 83.3) |
|
| |||||
|
| 100 (91.2 to 100) | 85 (70.2 to 94.3) | 98 (87.7 to 99.4) | 100 (90.8 to 100) | 100 (91.0 to 100) |
|
| 100 (91.2 to 100) | 90 (76.3 to 97.2) | 98 (87.7 to 99.4) | 97 (86.2 to 99.9) | 100 (91.0 to 100) |
|
| 98 (86.8 to 99.9) | 90 (76.3 to 97.2) | 95 (84.2 to 99.4) | 95 (82.3 to 99.4) | 100 (91.0 to 100) |
|
| |||||
|
| 100 | 63 (44.4 to 77.7) | 88 (50.2 to 98.0) | 100 | 100 |
|
| 100 | 71 (49.7 to 86.4) | 83 (40.5 to 97.4) | 92 (61.2 to 98.7) | 100 |
|
| 90 (56.2 to 98.4) | 71 (49.7 to 86.4) | 78 (47.5 to 93.1) | 82 (52.9 to 94.8) | 100 |
|
| |||||
|
| 98 (86.2 to 99.6) | 100 | 100 | 97 (85.3 to 99.6) | 89 (80.3 to 93.7) |
|
| 98 (86.2 to 99.6) | 100 | 96 (86.7 to 98.6) | 97 (85.0 to 99.6) | 95 (84.8 to 98.6) |
|
| 98 (85.9 to 99.6) | 100 | 100 | 93 (81.8 to 97.0) | 89 (80.3 to 93.7) |
O-RADS: Ovarian-Adnexal Reporting and Data System; PPV: Positive predictive value; NPV: Negative predictive value.
The sensitivity, specificity, positive predictive value and negative predictive value per Ovarian-Adnexal Reporting and Data System category for each reader on the post-training assessment
|
|
|
|
|
|
|
|
| |||||
|
| 100 (69.2 to 100) | 100 (69.2 to 100) | 100 (59 to 100) | 92 (61.5 to 99.8) | 73 (39 to 94) |
|
| 90 (55.5 to 99.8) | 90 (55.5 to 99.8) | 86 (42.1 to 99.6) | 92 (61.5 to 99.8) | 82 (48.2 to 97.7) |
|
| 100 (69.2 to 100) | 100 (69.2 to 100) | 100 (59 to 100) | 75 (42.8 to 94.5) | 64 (30.8 to 89.1) |
|
| |||||
|
| 100 (91.2 to 100) | 95 (83.1 to 99.4) | 98 (87.7 to 99.9) | 97 (86.2 to 99.9) | 100 (91 to 100) |
|
| 100 (91.2 to 100) | 98 (86.8 to 99.9) | 93 (80.9 to 98.5) | 95 (82.3 to 99.4) | 100 (91 to 100) |
|
| 100 (91.2 to 100) | 95 (83.1 to 99.4) | 91 (77.9 to 97.4) | 97 (86.2 to 99.9) | 100 (91 to 100) |
|
| |||||
|
| 100 | 83 (56.4 to 95.1) | 88 (50.2 to 98) | 92 (61.2 to 98.7) | 100 |
|
| 100 | 90 (56.2 to 98.4) | 67 (39.2 to 86.1) | 85 (58.5 to 95.5) | 100 |
|
| 100 | 83 (56.4 to 95.1) | 64 (40.8 to 81.7) | 90 (55.9 to 98.5) | 100 |
|
| |||||
|
| 100 | 100 | 100 | 97 (85 to 99.6) | 93 (83.2 to 97.2) |
|
| 98 (86.2 to 99.6) | 98 (85.9 to 99.6) | 98 (86.7 to 99.6) | 97 (84.6 to 99.6) | 95 (84.8 to 98.6) |
|
| 100 | 100 | 100 | 93 (82.2 to 97.1) | 91 (81.7 to 95.5) |
O-RADS: Ovarian-adnexal reporting and data system; PPV: Positive predictive value; NPV: Negative predictive value.
Misclassified ovarian-adnexal reporting and data system categories by readers in pre-training and post-training assessment
|
|
|
|
|
|
|
|
| Follicle defined as a simple cyst ≤ 3 cm | ORADS 2 | Follicle defined as a simple cyst ≤ 3 cm | 1 | 1 |
| Follicle defined as a simple cyst ≤ 3 cm | ORADS 2 | Simple cyst > 5 cm but < 10 cm | 1 | 0 | |
| Follicle defined as a simple cyst ≤ 3 cm | ORADS 3 | Multilocular cyst with smooth inner walls/septations < 10 cm, CS1-3 | 1 | 0 | |
|
| simple cyst > 3 cm to 5 cm | ORADS 3 | Unilocular cyst with irregular inner wall < 3mm height, any size | 0 | 1 |
|
| Multilocular cyst with smooth inner walls/septations, < 10 cm, CS1-3 | ORADS 2 | Simple cyst > 5 cm but < 10 cm | 1 | 0 |
| Multilocular cyst with smooth inner walls/septations, < 10 cm, CS1-3 | ORADS 4 | Multilocular cyst, irregular inner wall ± irregular septation | 0 | 1 | |
| Unilocular cyst (simple or non-simple) ≥ 10 cm | ORADS 4 | Unilocular cyst with 1-3 papillary projections | 1 | 0 | |
|
| Multilocular cyst, irregular inner wall ± irregular septation | ORADS 1 | Follicle defined as a simple cyst ≤ 3 cm | 1 | 0 |
| Multilocular cyst, irregular inner wall ± irregular septation | ORADS 2 | Classic benign lesion (hemorrhagic cyst < 10 cm) | 1 | 0 | |
| Multilocular cyst, irregular inner wall ± irregular septation | ORADS 3 | Typical dermoid cyst, endometrioma, hemorrhagic cyst ≥ 10 cm | 0 | 1 | |
| Multilocular cyst, irregular inner wall ± irregular septation | ORADS 3 | Multilocular cyst with smooth inner walls/septations < 10 cm, CS1-3 | 3 | 4 | |
|
| Solid lesion with irregular outer contour | ORADS 2 | Classic benign lesion (dermoid cyst < 10 cm) | 10 | 4 |
| Solid lesion with irregular outer contour | ORADS 3 | Solid lesion with smooth outer contour, any size, CS = 1 | 0 | 1 | |
| Solid lesion with irregular outer contour | ORADS 3 | Typical dermoid cyst, endometrioma, hemorrhagic cyst ≥ 10 cm | 0 | 1 | |
| Solid lesion with irregular outer contour | ORADS 4 | Unilocular cyst with solid component | 1 | 1 | |
| Solid lesion with irregular outer contour | ORADS 4 | Solid lesion with smooth outer contour, any size, CS = 2-3 | 0 | 2 | |
| Multilocular cyst with solid component, CS3-4 | ORADS 4 | Multilocular cyst with solid component, CS1-2 | 1 | 0 |
O-RADS: Ovarian-adnexal reporting and data system; CS: Color scor.
Figure 1Receiver operating characteristic curve. A: Receiver operating characteristic (ROC) curve of each reader on the pre-training assessment; B: ROC curve of each reader on the post-training assessment. AUC: Area under the curve.
Figure 2An example of a left ovarian solid lesion misclassified as a typical ovarian dermoid. A: Static gray-scale images; B: Static color Doppler ultrasound images. Static gray-scale and color Doppler ultrasound images shows a solid hypoechoic lesion with a non-uniform (irregular) margin demonstrated on the color Doppler image (Ovarian-Adnexal Reporting and Data System 5). The lesion demonstrates punctate echogenic areas (white asterisk) which are less echogenic than the surrounding pelvic fat (white arrow). Further, the echogenic areas do not fulfill one of the three descriptors required to characterize as a “typical dermoid cyst < 10 cm” according to ovarian-adnexal reporting and data system criteria (2). The hypoechoic lesion with posterior shadowing suggests a fibrous lesion.
Figure 3An example of a right ovarian cystic lesion misclassified as a “multilocular cyst < 10 cm, smooth inner wall, color score 1-3” (Ovarian-Adnexal Reporting and Data System 3). A: Static gray-scale images; B: Static color Doppler ultrasound images. Static gray-scale and color Doppler ultrasound images show a multilocular cyst with a subtle non-uniform (irregular) inner wall with solid components < 3 mm in height (white asterisk) (ovarian-adnexal reporting and data system 4) (2).